降钙素原用于烧伤患者脓毒症早期诊断的回顾性研究
该回顾性观察研究纳入150例烧伤面积≥15%的患者,比较脓毒症与非脓毒症组多种生物标志物,发现降钙素原(PCT)诊断脓毒症的AUC最大(0.71),优于白细胞、血小板、C反应蛋白等,建议在烧伤病房抗菌药物管理项目中考虑使用PCT。
要点
- 烧伤面积≥15%患者中,PCT诊断脓毒症的AUC为0.71,为所研究生物标志物中最大。
- PCT cut-off 0.5ng/mL灵敏度最高、特异度最低;1.5ng/mL灵敏度最低、特异度最高。
- 除体温外,所有生物标志物在脓毒症与非脓毒症组间差异有统计学意义,效应量中到大。
核心结论
- 降钙素原(PCT)是所研究生物标志物中诊断烧伤患者脓毒症早期诊断最佳者,应考虑用于烧伤病房抗菌药物管理项目。
研究设计与样本
- 回顾性观察研究,纳入150例总烧伤面积≥15%的烧伤患者,脓毒症临床诊断依据美国烧伤协会标准。
主要发现
- 无脓毒症组48例(2767个时间点),脓毒症组102例(652个时间点)。
- 除体温外,所有生物标志物在两组间差异有统计学意义,效应量中到大。
- PCT的AUC最大(AUC=0.71),效应量也最大。
- PCT ROC曲线分析显示,0.5ng/mL cut-off灵敏度最高、特异度最低;1.5ng/mL cut-off灵敏度最低、特异度最高。
关键数值与推荐
- 脓毒症临床诊断采用美国烧伤协会(ABA)标准。
- PCT诊断脓毒症AUC=0.71。
- PCT cut-off 0.5ng/mL:灵敏度最高、特异度最低;1.5ng/mL:灵敏度最低、特异度最高。
- 定量变量比较用Mann-Whitney检验,定性变量用Pearson卡方检验,效应量用优势概率衡量。
临床怎么用
- 在烧伤病房抗菌药物管理项目中可考虑使用PCT辅助脓毒症早期诊断。
- 解读PCT结果时需结合所选cut-off的灵敏度与特异度权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The gold standard for sepsis diagnosis in burn patient still relies on microbiological cultures, which take 48-72h to provide results, delaying the start of antimicrobial therapy. Thus, biomarkers allowing an earlier sepsis diagnosis in burn patients are needed. METHODS: This retrospective observational study included 150 burn patients with total burned surface area ≥15%. Clinical diagnosis of sepsis among these patients was done according to the American Burn Association criteria. Biomarker (procalcitonin, white blood cells and platelet countings, prothrombinemia, D-dimers, C-reactive protein, blood lactate and temperature) values were available for 48 patients without sepsis (2767 timepoints) and 102 patients with sepsis (652 timepoints). Quantitative variables were compared with Mann-Whitney tests and qualitative variables were compared with Pearson chi-square test. Effect size was measured by the probability of superiority. Receiver operating characteristic (ROC) curves evaluate capacity for sepsis diagnosis. Sensitivity, specificity, positive and negative predictive values were calculated for some cut-off values, including the best cut-off defined by the maximum of Youden index. RESULTS: Statistically significant differences between the groups of septic and non-septic patients, with medium to large effect size, were detected for all the biomarkers considered, except temperature. PCT was the biomarker with the largest AUC and effect size (AUC=0.71). Analysis of the PCT ROC curve showed that 0.5ng/mL cut-off presented highest sensitivity and lowest specificity, whereas 1.5ng/mL cut-off was associated with lowest sensitivity and highest specificity. CONCLUSION: Procalcitonin showed to be the best of the biomarkers studied for an early diagnosis of sepsis. Its use should be considered in antimicrobial stewardship programs in Burn Units.
引用
- Cabral L, Afreixo V, Santos F, et al. Procalcitonin for the early diagnosis of sepsis in burn patients: A retrospective study. Burns. 2017. PMID: 28454850. doi:10.1016/j.burns.2017.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。